Institutional Backing Fuels Optimism for Core Scientific Shares

Core Scientific is capturing significant investor attention following substantial institutional investment activity and recent insider purchases. This renewed interest comes despite the company’s failed acquisition by CoreWeave and persistent volatility in the broader market landscape.

Strategic Shift Shows Early Promise

The company’s latest quarterly results, released October 24, reveal a notable strategic transformation underway. While total revenue declined to $81.1 million from $95.4 million in the previous year, and Bitcoin mining revenue dropped by 55%, other segments showed promising growth. High-density colocation services revenue surged 45% to $15 million, and the net loss narrowed to $146.7 million. These figures indicate Core Scientific is successfully transitioning from a Bitcoin mining operation toward becoming a diversified AI infrastructure provider.

Major Institutional Investment Emerges

Oaktree Capital Management established a substantial position in Core Scientific during the third quarter of 2025. The investment powerhouse acquired 6.4 million shares valued at approximately $114.8 million as of September 30. This significant capital commitment arrived during a challenging period for the stock, which had already declined 34% since early November, signaling strong institutional confidence in the company’s long-term direction.

Insider Activity Signals Confidence

Corporate insiders have been actively accumulating positions, suggesting leadership believes the stock is undervalued. On November 12, a Core Scientific director purchased 30,000 Tranche-1 warrants at a weighted average price of $9.948 per warrant. This transaction followed earlier stock acquisitions by Director Eric Weiss on November 4, reinforcing the pattern of insider buying during the recent price weakness.

Should investors sell immediately? Or is it worth buying Core Scientific?

Failed Acquisition Paves Way for Independence

Shareholders rejected the proposed takeover by AI hyperscaler CoreWeave on October 30, maintaining Core Scientific’s independent status as a Nasdaq-listed company. This decision appears to have opened the door for the current strategic repositioning and attracted new institutional interest.

Analyst Consensus Remains Bullish

Market analysts maintain an optimistic outlook despite recent turbulence. The consensus among 14 research firms stands at “Buy” with an average price target of $22.04, representing potential upside of 47.6% from current trading levels.

The critical question remains whether Core Scientific can successfully execute its transformation from cryptocurrency miner to AI infrastructure provider. Current institutional investment patterns and insider buying activity suggest key stakeholders are betting on positive outcomes. The coming quarters will determine if this strategic repositioning delivers the anticipated results.